Literature DB >> 3514589

Distribution of two urinary ribonuclease-like enzymes in human organs and body fluids.

T Morita, Y Niwata, K Ohgi, M Ogawa, M Irie.   

Abstract

In order to determine the distribution of two human urinary RNase (RNase Us and RNase UL)-like enzymes in human tissues and body fluids, enzyme immunoassay systems were established using rabbit anti-RNase sera. The sensitivity of the assay systems was of similar order to that of radioimmunoassay systems previously reported. In the enzyme immunoassay, the cross reactivities of anti-RNase UL serum towards RNase Us, bovine kidney RNase K2, bovine RNase A, and bovine seminal RNase Vs were less than 1%. The cross reactivity of anti-RNase Us-serum towards RNase UL was less than 0.5% and cross reactivities were minimal for RNase A, RNase K2, and RNase Vs. The RNase levels in human organs and body fluids were measured by enzyme immunoassay. In milk, semen and saliva, only RNase UL-like enzyme was found. Both RNase Us- and RNase UL-like enzymes were found in kidney, stomach, and pancreas and the RNase Us/RNase UL ratios were 0.49, 1.35, and 0.34, respectively. In lung, liver, spleen, and leukocytes, most of the RNase activity was accounted for by RNase Us-like enzyme. The activity of RNase Us-like enzyme was especially high in lung, spleen, and leukocytes. The crude extracts of several tissues and body fluids were separated by phosphocellulose column chromatography and the contents of the two urinary RNase-like enzymes were determined by enzyme immunoassay. In stomach, kidney, pancreas, and serum, both enzymes were present in multiple forms. In spleen and lung, both the major RNase (RNase Us) and minor RNase (RNase UL) existed in two forms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514589     DOI: 10.1093/oxfordjournals.jbchem.a135456

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  18 in total

1.  Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions.

Authors:  M Moenner; E Hatzi; J Badet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

2.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

3.  Genetic polymorphism of human serum ribonuclease I (RNase I).

Authors:  T Yasuda; W Sato; K Mizuta; K Kishi
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

4.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family.

Authors:  H F Rosenberg; D G Tenen; S J Ackerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Comparative functional analysis of ribonuclease 1 homologs: molecular insights into evolving vertebrate physiology.

Authors:  Jo E Lomax; Chelcie H Eller; Ronald T Raines
Journal:  Biochem J       Date:  2017-06-21       Impact factor: 3.857

6.  Role of aspartic acid 121 in human pancreatic ribonuclease catalysis.

Authors:  Deepak Gaur; Janendra K Batra
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

7.  Consequences of the Endogenous N-Glycosylation of Human Ribonuclease 1.

Authors:  Valerie T Ressler; Ronald T Raines
Journal:  Biochemistry       Date:  2019-01-29       Impact factor: 3.162

8.  New sequence-specific human ribonuclease: purification and properties.

Authors:  G Przewlocki; J Lipecka; A Edelman; A Przykorska
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

9.  Revisiting the action of bovine ribonuclease A and pancreatic-type ribonucleases on double-stranded RNA.

Authors:  M Libonati; S Sorrentino
Journal:  Mol Cell Biochem       Date:  1992-11-18       Impact factor: 3.396

10.  Differences in glycosylation pattern of human secretory ribonucleases.

Authors:  J J Beintema; A Blank; G L Schieven; C A Dekker; S Sorrentino; M Libonati
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.